Obesity caused by a lifestyle of moving less and eating more is a prime factor contributing to Type 2 diabetes. Is the answer new weight loss drugs?

Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration ...

Popular weight-loss drug Wegovy maker Novo Nordisk expects high demand and acceptance for its anti-obesity drug, when ...

Novo Nordisk chief financial officer Karsten Munk Knudsen said on Wednesday the company was aware of reports of 10 deaths and ...

Novo Nordisk (NVO) teased some new details about a potential Ozempic successor during a call with investors Tuesday.The ...

Amanda Bynes was spotted for the first time since giving an update on her weight loss journey during an outing in Los Angeles ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...

or other injectable drugs, like a GLP-1 receptor agonist, to your treatment plan. If you have overweight, your doctor will usually recommend weight loss as one aspect of an overall treatment plan.

Third quarter sales of Novo’s in-demand obesity drug totaled $2.5 billion, roughly 81% higher than the same period in 2023 and nearly doubling the total for Lilly’s Zepbound.

Murray suffered the injury during training in the lead up to Australia's 22-10 defeat of New Zealand in Christchurch, ruling him out of Sunday's Pacific Cup final against Tonga at CommBank Stadium.